Three-year follow-up of accelerated transepithelial corneal cross-linking for progressive paediatric keratoconus.

CONCLUSIONS: ATE-CXL is a safe and effective treatment in paediatric progressive keratoconus patients, leading to stable keratometry and corneal thickness throughout the 36-month follow-up. PMID: 32051139 [PubMed - as supplied by publisher]
Source: The British Journal of Ophthalmology - Category: Opthalmology Authors: Tags: Br J Ophthalmol Source Type: research